Dr. Ana Jaklenec is a Research Scientist at Massachusetts Institute of Technology in the laboratory of Robert Langer at the David H Koch Institute for Integrative Cancer Research. Her group is focused on controlled delivery and stability of cell, biologic and small molecule therapeutics and has a strong focus on technologies for developing world applications.
Dr. Jaklenec holds a B.S. in Biomedical Engineering from Boston University and a Ph.D. in Biomedical Engineering from Brown University. She is also the recipient of the Ruth L. Kirschstein National Research Service Award (NRSA) from the National Institute of Health.
Dr. Jaklenec has secured and managed over 14 major competitive grants from government and private foundations including The Bill and Melinda Gates Foundation, NIH and the Norwegian Research Council. She has supervised over 50 pre and post doctorial students. Dr. Jaklenec has published over 25 peer reviewed articles, and has 16 issued and pending patents worldwide.
She is an active member of the Biomedical Engineering Society, Controlled Release Society and the Society of Biomaterials.